Biotech licenses protein production tech to Eli Lilly

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/peopleimages)
(Image: Getty/peopleimages)

Related tags: Protein, Eli lilly, Eli lilly and company, Technology, Dna, processing, development

ProteoNic licenses its 2G UNic technology to Eli Lilly for the development of the latter’s proprietary products.

Per the agreement, Eli Lilly receives non-exclusive commercial rights for the application of ProteoNic’s recombinant protein production technology. The licensee company will use this technology for future product development.

2G UNic is a mammalian protein expression technology designed to improve recombinant cell line production levels in host cells, selection systems, and protein targets. According to ProteoNic, this technology exerts a positive effect on recombinant protein production levels and on the stability of expression.

Additionally, ProteoNic licensed the same protein production technology to Aragen Bioscience. While ProteoNic was not able to provide further comment on its deal with Eli Lilly, ProteoNic’s spokesperson Victor Schut told us about the platform at the time of its deal with Aragen.

Schut told us, “We incorporate our DNA elements into existing client production vectors as an improvement of those vectors and production cell lines or we supply our own complete vectors. Both approaches result in higher protein production yields.”

Previously ProteoNic licensed​ a vector gene delivery system to Horizon Discovery. The licensed technology, CHOGUN, introduces genetic materials into CHO cells that lack the gene encoding enzyme glutamine synthetase, without using the toxic methionine sulphoximine material that is used in the traditional process.

Financial details of the agreement with Eli Lilly were not disclosed.

Related news

Related products

show more

Removing Aggregates of an Acidic Monoclonal Antibody

Removing Aggregates of an Acidic Monoclonal Antibody

Bio-Rad Laboratories | 22-Oct-2018 | Technical / White Paper

CHT Ceramic Hydroxyapatite Media/Resins are known as the industry gold standard for
impurity removal during monoclonal antibody (mAb) purification....

Single-Step Influenza and Dengue Virus Purification

Single-Step Influenza and Dengue Virus Purification

Bio-Rad Laboratories | 08-Oct-2018 | Application Note

CHT XT is the newest addition to the CHT family of media. It has been designed for superior physical robustness to ensure it can be used repeatedly over...

Downstream Purification of Large Biomolecules

Downstream Purification of Large Biomolecules

Bio-Rad Laboratories | 17-Sep-2018 | Research Study

Our newest strong anion exchange resin provides both high binding capacity and
high recovery, even at high flow rates. A rigid bead complete with...

Related suppliers

Follow us

Products

View more

Webinars